Recent advances involving the renin-angiotensin system - PubMed (original) (raw)

Review

Recent advances involving the renin-angiotensin system

Steven D Crowley et al. Exp Cell Res. 2012.

Abstract

The renin-angiotensin system (RAS) exercises fundamental control over sodium and water handling in the kidney. Accordingly, dysregulation of the RAS leads to blood pressure elevation with ensuing renal and cardiovascular damage. Recent studies have revealed that the RAS hormonal cascade is more complex than initially posited with multiple enzymes, effector molecules, and receptors that coordinately regulate the effects of the RAS on the kidney and vasculature. Moreover, recently identified tissue-specific RAS components have pleomorphic effects independent of the circulating RAS that influence critical homeostatic mechanisms including the immune response and fetal development. Further characterization of the diverse interactions between the RAS and other signaling pathways within specific tissues should lead to novel treatments for renal and cardiovascular disease.

PubMed Disclaimer

Figures

Fig. 1

Schematic of the renin–angiotensin system.

Cited by

Increased Frequency of Angiotensin-Converting Enzyme D Allele in Asian Patients With Chronic Obstructive Pulmonary Disease: An Updated Meta-Analysis.
Wu X, Li W, Luo Z, Chen Y. Wu X, et al. Clin Respir J. 2024 Aug;18(8):e70002. doi: 10.1111/crj.70002. Clin Respir J. 2024. PMID: 39188047 Free PMC article. Review.
ACE gene polymorphism and susceptibility to hypertension in a Jordanian adult population.
Al-Eitan L, Al-Khaldi S, Ibdah RK. Al-Eitan L, et al. PLoS One. 2024 Jun 25;19(6):e0304271. doi: 10.1371/journal.pone.0304271. eCollection 2024. PLoS One. 2024. PMID: 38917192 Free PMC article.
Modulation of ACE2/Ang1-7/Mas and ACE/AngII/AT1 axes affects anticancer properties of sertraline in MCF-7 breast cancer cells.
Fatehi R, Nouraei M, Panahiyan M, Rashedinia M, Firouzabadi N. Fatehi R, et al. Biochem Biophys Rep. 2024 May 23;38:101738. doi: 10.1016/j.bbrep.2024.101738. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38831897 Free PMC article.
Epithelial Transport in Disease: An Overview of Pathophysiology and Treatment.
Clemente-Suárez VJ, Martín-Rodríguez A, Redondo-Flórez L, Villanueva-Tobaldo CV, Yáñez-Sepúlveda R, Tornero-Aguilera JF. Clemente-Suárez VJ, et al. Cells. 2023 Oct 15;12(20):2455. doi: 10.3390/cells12202455. Cells. 2023. PMID: 37887299 Free PMC article. Review.
Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future.
Pijeira MSO, Nunes PSG, Chaviano SL, Diaz AMA, DaSilva JN, Ricci-Junior E, Alencar LMR, Chen X, Santos-Oliveira R. Pijeira MSO, et al. Curr Med Chem. 2024;31(34):5481-5534. doi: 10.2174/0929867331666230818092634. Curr Med Chem. 2024. PMID: 37594105 Review.

References

1. Benigni A., Corna D., Zoja C., Sonzogni A., Latini R., Salio M., Conti S., Rottoli D., Longaretti L., Cassis P., Morigi M., Coffman T.M., Remuzzi G. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest. 2009;119:524–530. - PMC - PubMed
1. Husain A., Graham R. Harwood Academic; Sydney: 2000. Drugs, Enzymes and Receptors of the Renin–Angiotensin System: Celebrating a Century of Discovery.
1. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 1991;325:293–302. - PubMed
1. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 1992;327:725–727. - PubMed
1. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 1993;329:1456–1462. - PubMed

Recent advances involving the renin-angiotensin system - PubMed (original) (raw)